Literature DB >> 8471179

Actin-sequestering ability of thymosin beta 4, thymosin beta 4 fragments, and thymosin beta 4-like peptides as assessed by the DNase I inhibition assay.

E Hannappel1, F Wartenberg.   

Abstract

Thymosin beta 4 containing 43 amino-acid residues belongs to a family of highly homologous peptides present at high concentrations in various species, cells, and tissues. Safer et al. [J. Biol. Chem. 266, 4029-4032 (1991)] have shown that thymosin beta 4 is an actin-sequestering peptide. Because DNase I is inhibited by G-actin and not by F-actin we employed this enzymatic assay to determine the actin sequestering properties of 4 other thymosin beta 4-like peptides and fragments of thymosin beta 4 generated by enzymatic digestions. Thymosin beta 4 sequesters G-actin at a 1 to 1 ratio an thereby inhibits its polymerisation to F-actin in high salt solution. The oxidation of the single methionine residue at position 6 does not abolish its actin-sequestering properties. However neither thymosin beta 4 24-43 nor thymosin beta 4 13-43 inhibit the polymerisation of G-actin. We conclude from this that some structural features in the amino-acid sequence of thymosin beta 4 before position 13 are obligatory for its biological function. Oxidized thymosin beta 4 (beta 4-sulfoxide) as well as four other thymosin beta 4-like peptides were shown to be actin-sequestering peptides like thymosin beta 4.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8471179     DOI: 10.1515/bchm3.1993.374.1-6.117

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  9 in total

1.  Thymosin-beta(4) changes the conformation and dynamics of actin monomers.

Authors:  E M De La Cruz; E M Ostap; R A Brundage; K S Reddy; H L Sweeney; D Safer
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

Review 2.  Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche.

Authors:  Gemma M Balmer; Paul R Riley
Journal:  J Cardiovasc Transl Res       Date:  2012-06-15       Impact factor: 4.132

3.  Distribution and biological activity ofβ-thymosins.

Authors:  M Mihelić; W Voelter
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

4.  Mapping the binding site of thymosin beta4 on actin by competition with G-actin binding proteins indicates negative co-operativity between binding sites located on opposite subdomains of actin.

Authors:  E Ballweber; E Hannappel; T Huff; H G Mannherz
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

5.  Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice.

Authors:  William J Mason; Daniyal J Jafree; Gideon Pomeranz; Maria Kolatsi-Joannou; Antje K Rottner; Sabrina Pacheco; Dale A Moulding; Anja Wolf; Christian Kupatt; Claire Peppiatt-Wildman; Eugenia Papakrivopoulou; Paul R Riley; David A Long; Elisavet Vasilopoulou
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

Review 6.  The beta-thymosins, small actin-binding peptides widely expressed in the developing and adult cerebellum.

Authors:  Jaime Gómez-Márquez; Ramón Anadón
Journal:  Cerebellum       Date:  2002-04       Impact factor: 3.847

7.  Interaction of G-actin with thymosin beta 4 and its variants thymosin beta 9 and thymosin beta met9.

Authors:  C Jean; K Rieger; L Blanchoin; M F Carlier; M Lenfant; D Pantaloni
Journal:  J Muscle Res Cell Motil       Date:  1994-06       Impact factor: 2.698

8.  Widely distributed residues in thymosin beta4 are critical for actin binding.

Authors:  Joshua K Au; Adrian O Olivares; Arnon Henn; Wenxiang Cao; Daniel Safer; Enrique M De La Cruz
Journal:  Biochemistry       Date:  2008-03-08       Impact factor: 3.162

Review 9.  Focusing on unpolymerized actin.

Authors:  M Fechheimer; S H Zigmond
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.